Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingfeng Tang

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
The EMBO Journal|December 15, 2022
Host range and structural analysis of bat-origin RshSTT182/200 coronavirus binding to human ACE2 and its animal orthologsYu Hu, Kefang Liu, Pu Han, et al.
Thoracic Cancer|July 13, 2019
Extracorporeal membrane oxygenation (ECMO) assisted mediastinal tumor resection and superior vena cava replacement are safe and feasibleShixin Zhang, Deli Tan, Wei Wu, et al.
Bioorganic Chemistry|April 8, 2026
Discovery of a potent and orally available SOS1 inhibitor with antitumor efficacy in KRAS-mutant colorectal cancersXingchen Liu, Yuzhou Xiao, Lingfeng Tang, et al.
Journal of Medicinal Chemistry|June 5, 2026
Discovery of Highly Potent and Selective SOS1 Inhibitors for the Treatment of KRAS-Driven Colorectal CancerXingchen Liu, Yuzhou Xiao, Yanmei Zhou, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
The EMBO Journal|December 15, 2022
Host range and structural analysis of bat-origin RshSTT182/200 coronavirus binding to human ACE2 and its animal orthologsYu Hu, Kefang Liu, Pu Han, et al.
Thoracic Cancer|July 13, 2019
Extracorporeal membrane oxygenation (ECMO) assisted mediastinal tumor resection and superior vena cava replacement are safe and feasibleShixin Zhang, Deli Tan, Wei Wu, et al.
Bioorganic Chemistry|April 8, 2026
Discovery of a potent and orally available SOS1 inhibitor with antitumor efficacy in KRAS-mutant colorectal cancersXingchen Liu, Yuzhou Xiao, Lingfeng Tang, et al.
Journal of Medicinal Chemistry|June 5, 2026
Discovery of Highly Potent and Selective SOS1 Inhibitors for the Treatment of KRAS-Driven Colorectal CancerXingchen Liu, Yuzhou Xiao, Yanmei Zhou, et al.
Pageof 4